Study wrapper · #885
Thermosensitive Hydrogels for Sustained Semaglutide Release: Overcoming Weight Loss Plateau in Diet-Induced Obese Rats.
Wang J, Hu H, Long L, et al. Pharmaceutical development and technology. 2026.
DOI: 10.1080/10837450.2026.2703559PubMed: 42454991
Editor's note
This is a drug-delivery formulation study using a thermosensitive hydrogel to extend semaglutide release in obese rats. Semaglutide is genuinely the subject, but the work is about the delivery system rather than the drug's efficacy, and results are preclinical. Weight for the peptide itself is modest.
Plain-language abstract
Researchers developed a temperature-sensitive gel that slowly releases semaglutide, and in obese rats it produced continuous weight loss over 20 days while improving lipid and liver markers.
Related coverage
Mixed
Hunger pain and its reduction; qualitative insight from people with schizophrenia on semaglutide.
International journal of qualitative studies on health and well-beingn=——2026
Weak / none
Design, synthesis, and stability evaluation of semaglutide-derived lactam-stapled peptide scaffolds for GLP-1R targeting.
Journal of enzyme inhibition and medicinal chemistryn=——2026
Mixed
Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study.
Journal of obstetrics and gynaecologyn=——2026